Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
REACH--the new European chemicals law.

Environmental science & technology

Lahl U, Hawxwell KA.
PMID: 17180957
Environ Sci Technol. 2006 Dec 01;40(23):7115-21. doi: 10.1021/es062984j.

No abstract available.

Cite
Lahl U, Hawxwell KA. REACH--the new European chemicals law. Environ Sci Technol. 2006;40(23):7115-21doi: 10.1021/es062984j.
Lahl, U., & Hawxwell, K. A. (2006). REACH--the new European chemicals law. Environmental science & technology, 40(23), 7115-21. https://doi.org/10.1021/es062984j
Lahl, Uwe, and Hawxwell, Katrin Anne. "REACH--the new European chemicals law." Environmental science & technology vol. 40,23 (2006): 7115-21. doi: https://doi.org/10.1021/es062984j
Lahl U, Hawxwell KA. REACH--the new European chemicals law. Environ Sci Technol. 2006 Dec 01;40(23):7115-21. doi: 10.1021/es062984j. PMID: 17180957.
Copy Download .nbib Format: NLM
[Patient education: regarding risks and adverse reactions].

Deutsche medizinische Wochenschrift (1946)

Ospelt N.
PMID: 27097383
Dtsch Med Wochenschr. 2016 Jan;141(1):64-5.

No abstract available.

Cite
Ospelt N. Patientenaufklärung: Zu Risiken und Nebenwirkungen. [Patient education: regarding risks and adverse reactions]. Dtsch Med Wochenschr. 2016;141(1):64-5
Ospelt, N. (2016). Patientenaufklärung: Zu Risiken und Nebenwirkungen. [Patient education: regarding risks and adverse reactions]. Deutsche medizinische Wochenschrift (1946), 141(1), 64-5.
Ospelt, Nina. "Patientenaufklärung: Zu Risiken und Nebenwirkungen." [Patient education: regarding risks and adverse reactions]. Deutsche medizinische Wochenschrift (1946) vol. 141,1 (2016): 64-5.
Ospelt N. Patientenaufklärung: Zu Risiken und Nebenwirkungen. [Patient education: regarding risks and adverse reactions]. Dtsch Med Wochenschr. 2016 Jan;141(1):64-5. German. PMID: 27097383.
Copy Download .nbib Format: NLM
[Innovations introduced by the legislative decree of 3 August 2009, No. 106, related to the risk assessment of work-related stress].

Giornale italiano di medicina del lavoro ed ergonomia

Fantini L.
PMID: 21438238
G Ital Med Lav Ergon. 2010 Oct-Dec;32(4):138-40.

No abstract available.

Cite
Fantini L. Le innovazioni introdotte dal decreto legislative 3 agosto 2009, n. 106, in materia di valutazione dei rischi da stress lavoro-correlato. [Innovations introduced by the legislative decree of 3 August 2009, No. 106, related to the risk assessment of work-related stress]. G Ital Med Lav Ergon. 2010;32(4):138-40
Fantini, L. (2010). Le innovazioni introdotte dal decreto legislative 3 agosto 2009, n. 106, in materia di valutazione dei rischi da stress lavoro-correlato. [Innovations introduced by the legislative decree of 3 August 2009, No. 106, related to the risk assessment of work-related stress]. Giornale italiano di medicina del lavoro ed ergonomia, 32(4), 138-40.
Fantini, L. "Le innovazioni introdotte dal decreto legislative 3 agosto 2009, n. 106, in materia di valutazione dei rischi da stress lavoro-correlato." [Innovations introduced by the legislative decree of 3 August 2009, No. 106, related to the risk assessment of work-related stress]. Giornale italiano di medicina del lavoro ed ergonomia vol. 32,4 (2010): 138-40.
Fantini L. Le innovazioni introdotte dal decreto legislative 3 agosto 2009, n. 106, in materia di valutazione dei rischi da stress lavoro-correlato. [Innovations introduced by the legislative decree of 3 August 2009, No. 106, related to the risk assessment of work-related stress]. G Ital Med Lav Ergon. 2010 Oct-Dec;32(4):138-40. Italian. PMID: 21438238.
Copy Download .nbib Format: NLM
Risk assessment in the law: legal admissibility, scientific validity, and some disparities between research and practice.

Behavioral sciences & the law

Krauss DA, Scurich N.
PMID: 23613165
Behav Sci Law. 2013 Mar-Apr;31(2):215-29. doi: 10.1002/bsl.2065. Epub 2013 Apr 24.

Risk assessment expert testimony remains an area of considerable concern within the U.S. legal system. Historically, controversy has surrounded the constitutionality of such testimony, while more recently, following the adoption of new evidentiary standards that focus on scientific validity,...

Cite
Krauss DA, Scurich N. Risk assessment in the law: legal admissibility, scientific validity, and some disparities between research and practice. Behav Sci Law. 2013;31(2):215-29doi: 10.1002/bsl.2065.
Krauss, D. A., & Scurich, N. (2013). Risk assessment in the law: legal admissibility, scientific validity, and some disparities between research and practice. Behavioral sciences & the law, 31(2), 215-29. https://doi.org/10.1002/bsl.2065
Krauss, Daniel A, and Scurich, Nicholas. "Risk assessment in the law: legal admissibility, scientific validity, and some disparities between research and practice." Behavioral sciences & the law vol. 31,2 (2013): 215-29. doi: https://doi.org/10.1002/bsl.2065
Krauss DA, Scurich N. Risk assessment in the law: legal admissibility, scientific validity, and some disparities between research and practice. Behav Sci Law. 2013 Mar-Apr;31(2):215-29. doi: 10.1002/bsl.2065. Epub 2013 Apr 24. PMID: 23613165.
Copy Download .nbib Format: NLM
Modeling for regulatory purposes (risk and safety assessment).

Methods in molecular biology (Clifton, N.J.)

El-Masri H.
PMID: 23086847
Methods Mol Biol. 2013;930:297-303. doi: 10.1007/978-1-62703-059-5_13.

Chemicals provide many key building blocks that are converted into end-use products or used in industrial processes to make products that benefit society. Ensuring the safety of chemicals and their associated products is a key regulatory mission. Current processes...

Cite
El-Masri H. Modeling for regulatory purposes (risk and safety assessment). Methods Mol Biol. 2013;930:297-303doi: 10.1007/978-1-62703-059-5_13.
El-Masri, H. (2013). Modeling for regulatory purposes (risk and safety assessment). Methods in molecular biology (Clifton, N.J.), 930297-303. https://doi.org/10.1007/978-1-62703-059-5_13
El-Masri, Hisham. "Modeling for regulatory purposes (risk and safety assessment)." Methods in molecular biology (Clifton, N.J.) vol. 930 (2013): 297-303. doi: https://doi.org/10.1007/978-1-62703-059-5_13
El-Masri H. Modeling for regulatory purposes (risk and safety assessment). Methods Mol Biol. 2013;930:297-303. doi: 10.1007/978-1-62703-059-5_13. PMID: 23086847.
Copy Download .nbib Format: NLM
Considerations on the EU definition of a nanomaterial: science to support policy making.

Regulatory toxicology and pharmacology : RTP

Bleeker EA, de Jong WH, Geertsma RE, Groenewold M, Heugens EH, Koers-Jacquemijns M, van de Meent D, Popma JR, Rietveld AG, Wijnhoven SW, Cassee FR, Oomen AG.
PMID: 23200793
Regul Toxicol Pharmacol. 2013 Feb;65(1):119-25. doi: 10.1016/j.yrtph.2012.11.007. Epub 2012 Nov 29.

In recent years, an increasing number of applications and products containing or using nanomaterials have become available. This has raised concerns that some of these materials may introduce new risks for humans or the environment. A clear definition to...

Cite
Bleeker EA, de Jong WH, Geertsma RE, et al. Considerations on the EU definition of a nanomaterial: science to support policy making. Regul Toxicol Pharmacol. 2012;65(1):119-25doi: 10.1016/j.yrtph.2012.11.007.
Bleeker, E. A., de Jong, W. H., Geertsma, R. E., Groenewold, M., Heugens, E. H., Koers-Jacquemijns, M., van de Meent, D., Popma, J. R., Rietveld, A. G., Wijnhoven, S. W., Cassee, F. R., & Oomen, A. G. (2013). Considerations on the EU definition of a nanomaterial: science to support policy making. Regulatory toxicology and pharmacology : RTP, 65(1), 119-25. https://doi.org/10.1016/j.yrtph.2012.11.007
Bleeker, Eric A J, et al. "Considerations on the EU definition of a nanomaterial: science to support policy making." Regulatory toxicology and pharmacology : RTP vol. 65,1 (2013): 119-25. doi: https://doi.org/10.1016/j.yrtph.2012.11.007
Bleeker EA, de Jong WH, Geertsma RE, Groenewold M, Heugens EH, Koers-Jacquemijns M, van de Meent D, Popma JR, Rietveld AG, Wijnhoven SW, Cassee FR, Oomen AG. Considerations on the EU definition of a nanomaterial: science to support policy making. Regul Toxicol Pharmacol. 2013 Feb;65(1):119-25. doi: 10.1016/j.yrtph.2012.11.007. Epub 2012 Nov 29. PMID: 23200793.
Copy Download .nbib Format: NLM
Proportionate and scientifically sound risk assessment of gene-edited plants.

EMBO reports

Casacuberta JM, Puigdomènech P.
PMID: 30185424
EMBO Rep. 2018 Oct;19(10). doi: 10.15252/embr.201846907. Epub 2018 Sep 05.

No abstract available.

Cite
Casacuberta JM, Puigdomènech P. Proportionate and scientifically sound risk assessment of gene-edited plants. EMBO Rep. 2018;19(10)doi: 10.15252/embr.201846907.
Casacuberta, J. M., & Puigdomènech, P. (2018). Proportionate and scientifically sound risk assessment of gene-edited plants. EMBO reports, 19(10), . https://doi.org/10.15252/embr.201846907
Casacuberta, Josep M, and Puigdomènech, Pere. "Proportionate and scientifically sound risk assessment of gene-edited plants." EMBO reports vol. 19,10 (2018). doi: https://doi.org/10.15252/embr.201846907
Casacuberta JM, Puigdomènech P. Proportionate and scientifically sound risk assessment of gene-edited plants. EMBO Rep. 2018 Oct;19(10). doi: 10.15252/embr.201846907. Epub 2018 Sep 05. PMID: 30185424; PMCID: PMC6172455.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries